Free Delivery Over $100
|
|
|||
|
||||
OverviewMany experts now consider genetic evaluation to be pivotal for the optimal diagnosis, classification, risk stratification, and therapeutic decision-making for persons diagnosed with blood cancer. This new text specifically focuses on the genetic alterations essential for establishing diagnosis and assesses how they might impact the precision oncology standard of care. Providing an authoritative review of the state of the art, this is essential reading for physicians, hematologists, and oncologists for optimal management of individual patients. Full Product DetailsAuthor: Tariq Mughal (Tufts University Medical Center, Boston, Massachusetts, USA, Kings College NHS Foundation Trust, London, and University of Buckingham Medical School, UK)Publisher: Taylor & Francis Inc Imprint: CRC Press Inc Weight: 0.632kg ISBN: 9781498746991ISBN 10: 1498746993 Pages: 242 Publication Date: 02 November 2018 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Tertiary & Higher Education Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTariq I Mughal, MD, FRCP, FACP, graduated in medicine from St George's Hospital Medical School, London, and trained in hematology, medical oncology and stem cell transplantation at the University of Colorado Health Sciences Center, Denver. He is Clinical Professor of Medicine at Tufts University School of Medicine, Boston, Consultant Hematologist at Kings College NHS Foundation Trust, London, Professor of Hematology and Oncology at the University of Buckingham Medical School, UK, and the founder of Apline Oncology Foundation. Tab Content 6Author Website:Countries AvailableAll regions |
||||
